Journal article
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
- Abstract:
-
INTRODUCTION Rheumatoid Arthritis is a systemic inflammatory disease and classical disease-modifying anti-rheumatic drugs (cDMARDs) have proven efficacy. It is unknown what impact cDMARDs might have on dementia as an outcome.
METHODS Incident diagnoses of Rheumatoid Arthritis in persons over 18 years from 1995 to 2011 were identified from the UK Clinical Practice Research Datalink. 3,876 cDMARD users were propensity score matched to 1,938 non-users, on a wide range of confounders....
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Roche-Chugai
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions Journal website
- Volume:
- 3
- Issue:
- 4
- Pages:
- 612-621
- Publication date:
- 2017-11-09
- Acceptance date:
- 2017-10-11
- DOI:
- EISSN:
-
2352-8737
- Source identifiers:
-
735197
Item Description
- Keywords:
- Pubs id:
-
pubs:735197
- UUID:
-
uuid:5d2e68ef-cec6-4c09-bd2f-e1cfdf1ffcc0
- Local pid:
- pubs:735197
- Deposit date:
- 2017-10-12
Terms of use
- Copyright holder:
- Judge et al
- Copyright date:
- 2017
- Notes:
-
© 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
If you are the owner of this record, you can report an update to it here: Report update to this record